Alpha 2.0
Login Register
» Authors » K Goyal

K Goyal

Explore the profile of K Goyal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 302
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Dermatology
Top 10 Co-Authors
M P Singh
S Fakharzadeh
A Goyal
A Menter
M O Fitzpatrick
A B Kimball
S Calabro
A Kumar
A Ghosh
M Chevrier
Published In
J Eur Acad Dermatol Venereol
Br J Dermatol
Indian J Med Microbiol
J Clin Anesth
Public Health
Affiliations
Soon will be listed here.
Recent Articles
1.
A guide to empirical management of urinary tract infection in outpatient setting in a tertiary care institute: A study from Western India
Rajni E, Goyal K, Sharma R
J Postgrad Med . 2025 Mar; PMID: 40085075
Introduction: Urinary tract infections make up a major proportion of infections encountered in outpatient setting in hospitals. Treatment is largely based on the epidemiology of locally prevalent flora. Selection of...
2.
High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021)
Ghosh A, Goyal K, Singh R, Lakshmi P, Kaur R, Kumar V, et al.
Public Health . 2023 Nov; 225:160-167. PMID: 37931485
Objective: Current national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination policy covers children aged >12 years. Unvaccinated, uninfected children remain susceptible to SARS-CoV-2 and play a role in community...
3.
Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma
Goyal A, OLeary D, Goyal K, Rubin N, Janakiram M
J Eur Acad Dermatol Venereol . 2021 May; 35(9):1821-1829. PMID: 34013554
Background: Patients with mycosis fungoides (MF) are at increased risk of developing non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung cancer, bladder cancer and melanoma. The characteristics of patients developing these...
4.
SARS-CoV-2 Detection in Gingival Crevicular Fluid
Gupta S, Mohindra R, Chauhan P, Singla V, Goyal K, Sahni V, et al.
J Dent Res . 2020 Nov; 100(2):187-193. PMID: 33138663
Understanding the pathophysiology of the coronavirus disease 2019 (COVID-19) infection remains a significant challenge of our times. The gingival crevicular fluid being representative of systemic status and having a proven...
5.
Mycosis fungoides: developments in incidence, treatment and survival
Kaufman A, Patel K, Goyal K, OLeary D, Rubin N, Pearson D, et al.
J Eur Acad Dermatol Venereol . 2020 Mar; 34(10):2288-2294. PMID: 32141115
Background: Prior studies have demonstrated improved disease-specific survival of mycosis fungoides (MF) patients over the last 50 years. Objective: To analyse patterns of survival and incidence from 1973 to 2016...
6.
Coinfection of H1N1 Influenza and Scrub Typhus-A Review
Jhuria L, Muthu V, Gupta S, Singh M, Biswal M, Goyal K, et al.
QJM . 2020 Feb; 113(7):465-468. PMID: 32031635
The H1N1 influenza infection usually coincides with the typical scrub typhus season in North India. This leads to diagnostic difficulties due to their similar and non-specific symptoms. We describe three...
7.
Epidemiology of primary cutaneous γδ T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis
Goyal A, Goyal K, Bohjanen K, Pearson D
Br J Dermatol . 2019 Apr; 181(4):848-850. PMID: 30951189
No abstract available.
8.
Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Kimball A, Augustin M, Gordon K, Krueger G, Pariser D, Fakharzadeh S, et al.
Br J Dermatol . 2018 May; 179(4):984-986. PMID: 29747219
No abstract available.
9.
Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Shear N, Alhusayen R, Fernandez-Obregon A, Kimball A, Menter A, Wu J, et al.
J Eur Acad Dermatol Venereol . 2017 Jun; 31(12):e544-e547. PMID: 28622413
No abstract available.
10.
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)
Blauvelt A, Ferris L, Yamauchi P, Qureshi A, Leonardi C, Farahi K, et al.
Br J Dermatol . 2017 Jun; 177(6):1552-1561. PMID: 28600818
Background: Phase III studies showed that some patients maintained response for ≥ 6 months following ustekinumab discontinuation. Objectives: To assess clinical responses with extended ustekinumab maintenance dosing intervals. Methods: Adults...